Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_4
1
20%
Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (20.0%)
N/A4 (80.0%)

Trials by Status

completed360%
terminated120%
unknown120%

Recent Activity

0 active trials
Showing 5 of 5
unknownnot_applicable

Explore the Effect of Gynostemma Pentaphyllum on Patients With Metabolic Syndrome

NCT05118698
completednot_applicable

Duckweed Intake Study

NCT03677583
completednot_applicable

Vegetable Signature From Human Metabolomics Responses

NCT03483558
terminatednot_applicable

Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application

NCT02758990
completedphase_4

Nitrate Supplementation; Source

NCT02271633

Clinical Trials (5)

Showing 5 of 5 trials
NCT05118698Not Applicable

Explore the Effect of Gynostemma Pentaphyllum on Patients With Metabolic Syndrome

Unknown
NCT03677583Not Applicable

Duckweed Intake Study

Completed
NCT03483558Not Applicable

Vegetable Signature From Human Metabolomics Responses

Completed
NCT02758990Not Applicable

Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application

Terminated
NCT02271633Phase 4

Nitrate Supplementation; Source

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5